There is one clinical trial.
1. Develop a wearable sensor package to gather data on COVID-19-like signs and symptoms such as elevated body temperature, respiratory parameters, heart rate ,cough and gait. 2. Create algorithms to monitor and track changes to COVID19-like signs and symptoms for developing a better care and isolation strategies for COVID-19 pandemic.
Description: Body temperature : Periodic temperature readings over the day (every 15 minutes)Measure: Body temperature Time: Minimum 7 days from day 1 of study enrollment up to 60 days
Description: Number of coughing episodes in an hourMeasure: Cough Frequency Time: Minimum 7 days from day 1 of study enrollment up to 60 days
Description: Number of breaths per minuteMeasure: Respiratory frequency Time: Minimum 7 days from day 1 of study enrollment up to 60 days
Description: Instantaneous heart rate every 15 minutesMeasure: Heart Rate Instantaneous heart rate every 15 minutes. Time: Minimum 7 days from day 1 of study enrollment up to 60 days
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports